Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Polaris Group

Clinical trials sponsored by Polaris Group, explained in plain language.

Polaris Group 6550 TWSE

Biopharmaceutical company developing cancer therapies.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Not yet finished but already full! 1 Terminated 1

Experimental combo targets leukemia by starving cancer cells

Disease control Ongoing

This early-phase trial tests a new drug called ADI-PEG 20 added to two standard chemotherapy drugs (venetoclax and azacitidine) for people with acute myeloid leukemia (AML). The study includes 38 adults with either relapsed/refractory AML or newly diagnosed AML who cannot have in…

Phase: PHASE1 • Sponsor: Polaris Group • Aim: Disease control

Last updated Jun 27, 2026 08:12 UTC